Jobs / United States / Natera INC
Clinical Oncology Specialist, Breast
Natera INC · 🇺🇸 Philadelphia, PA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Natera INC paid sponsored hires in similar roles1 certified filing for “Clinical Lab Scientist I” (Medical and Clinical Laboratory Technologists) in CA: $86k–$86k, median $86k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Natera INC
The US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Natera INC →
About the role
LOCATION: The territory is the Keystone region and includes the Eastern Shore, New Jersey, and Philadelphia areas, with a preference for candidates based in Philadelphia. We’re looking for a dynamic Clinical Oncology Specialist (COS) to join our newly established Breast Oncology specialty team . This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera—our groundbreaking, first-in-class MRD ctDNA test. As a COS, you’ll act as a strategic field partner and a key representative of Natera Oncology, collaborating cross-functionally to engage key opinion leaders (KOLs) across integrated delivery networks, academic medical centers, hospital systems, and select community oncology practices. Primary stakeholders include Breast Surgeons, Breast Radiologists, Radiation Oncologist, Medical Oncologists and Pathologists. Success in this role demands a deep understanding of the breast oncology space, strong clinical acumen, and the ability to navigate complex healthcare systems while fostering trusted, value-driven relationships. We’re seeking individuals who thrive in a fast-paced, entrepreneurial environment and are driven by purpose, passion, and the pursuit of clinical excellence. Frequent travel is required. Key Responsibilitie s • Develop and execute a strategic territory plan focused on growth and account penetration • Identify and engage KOLs and key accounts to integrate Signatera into clinical decision-making • Drive new business development while expanding and deepening existing relationships • Maximize return on investment through consistent sales activity and cross-functional collaboration • Deliver impactful clinical education to physicians and care teams • Serve as a trusted resource in a fast-paced, startup-like environment • Build deep understanding of Natera’s oncology solutions, internal processes, and competitor landscape • Call on targeted physicians and practices to promote Natera’s oncology products and services • Drive product adoption by influencing clinical decision-making at the provider and system level • Monitor account performance and market trends; escalate issues and identify new opportunities • Consistently conduct business in an ethical, transparent, and professional manner Qualifications • Bachelor’s degree required • 5+ years of successful experience in breast oncology, surgical sales, or molecular diagnostics preferred • Deep knowledge of academic and community oncology markets, precision medicine, and reimbursement landscape • Ability to travel frequently, including overnight travel as needed • Valid driver’s license and safe driving record • Proven leadership, business acumen, and strong communication skills • Travel: ~75% (combination of road and air travel) Key Competencies • Excellent verbal, written, and presentation skills • Strategic, forward-thinking, and data-driven mindset • Ability to work independently and collaboratively in team environments • Strong clinical understanding of oncology and molecular diagnostics • Comfortable navigating complex healthcare systems and engaging senior stakeholders. Total compensation includes a competitive base salary and uncapped quarterly commissions. In addition we offer a car allowance and Restricted Stock Units (RSUs). The compensation package listed is for 1st year OTE, which are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. On-target earnings (OTE) represent the total potential income an employee can earn by achieving 100% of their performance goals. It combines a base salary with commissions and serves as an estimated figure rather than a guaranteed amount,